Synonym
SGE-301; SGE 301; SGE301;
IUPAC/Chemical Name
(3S,8S,9S,10R,13R,14S,17R)-17-((R)-5-hydroxy-5-methylhexan-2-yl)-3,10,13-trimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
InChi Key
GLXBRGHIMATFKV-ABXCMAEBSA-N
InChi Code
InChI=1S/C27H46O2/c1-18(11-13-24(2,3)28)21-9-10-22-20-8-7-19-17-25(4,29)15-16-26(19,5)23(20)12-14-27(21,22)6/h7,18,20-23,28-29H,8-17H2,1-6H3/t18-,20+,21-,22+,23+,25+,26+,27-/m1/s1
SMILES Code
CC(C)(O)CC[C@@H](C)[C@H]1CC[C@@]2([H])[C@]3([H])CC=C4C[C@](O)(C)CC[C@]4(C)[C@@]3([H])CC[C@]12C
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
402.66
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: La DS, Salituro FG, Martinez Botella G, Griffin AM, Bai Z, Ackley MA, Dai J,
Doherty JJ, Harrison BL, Hoffmann EC, Kazdoba TM, Lewis MC, Quirk MC, Robichaud
AJ. Neuroactive Steroid N-Methyl-d-aspartate Receptor Positive Allosteric
Modulators: Synthesis, SAR, and Pharmacological Activity. J Med Chem. 2019 Aug
13. doi: 10.1021/acs.jmedchem.9b00591. [Epub ahead of print] PubMed PMID:
31390523.
2: Warikoo N, Brunwasser SJ, Benz A, Shu HJ, Paul SM, Lewis M, Doherty J, Quirk
M, Piccio L, Zorumski CF, Day GS, Mennerick S. Positive Allosteric Modulation as
a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis. J Neurosci.
2018 Mar 28;38(13):3218-3229. doi: 10.1523/JNEUROSCI.3377-17.2018. Epub 2018 Feb
23. PubMed PMID: 29476014; PubMed Central PMCID: PMC6596063.
3: Sun MY, Izumi Y, Benz A, Zorumski CF, Mennerick S. Endogenous
24S-hydroxycholesterol modulates NMDAR-mediated function in hippocampal slices. J
Neurophysiol. 2016 Mar;115(3):1263-72. doi: 10.1152/jn.00890.2015. Epub 2015 Dec
23. PubMed PMID: 26745248; PubMed Central PMCID: PMC4808088.